NIRAMAI Health Analytix vs OpenEvidence
Which Healthcare AI tool is better in 2026?
NIRAMAI Health Analytix
A novel AI-based medical device for early, accurate, portable, and privacy-aware breast cancer detection.
OpenEvidence
AI medical assistant for clinicians
Side-by-side
OpenEvidence is the more established option (raised $735M); pricing is comparable on both sides.
| Metric | NIRAMAI Health Analytix | OpenEvidence |
|---|---|---|
| Taglinei | A novel AI-based medical device for early, accurate, portable, and privacy-aware breast cancer detection. | AI medical assistant for clinicians |
| Foundedi | — | 2022🏆 |
| HQi | IN | San Francisco, US |
| Employeesi | 51-200🏆 | 50-200 |
| Neuron scorei | 31 | 63🏆 |
| Total fundingi | Undisclosed | $735M🏆 |
| Latest roundi | — | Series D · Jan 2026 |
| Valuationi | — | $12B🏆 |
| Cheapest paid plani | Pricing not disclosed | — |
| Free plani | ✗ | ✓ Free for Verified US Physicians |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | — |
| Pricing summaryi | Enterprise · Contact sales | 1 published plans |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for NIRAMAI Health Analytix and OpenEvidence.
| Capability | NIRAMAI Health Analytix | OpenEvidence |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✓ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | 2 (TypeScript, Python) |
| Free plan | ✗ | ✓ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✓ |
| Active deal | ✗ | ✗ |
🟢 Strengths of NIRAMAI Health Analytix
- Strong in AI Healthcare
🔵 Strengths of OpenEvidence
- Has raised more capital ($735M vs Undisclosed)
- Higher Neuron score (63 vs 31)
- Offers a free plan
- Newer company (2022)
Which should you choose?
Choose OpenEvidence if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
NIRAMAI Health Analytix vs OpenEvidence — which is better?
It depends on your priority. NIRAMAI Health Analytix is the leaner option; OpenEvidence has broader feature depth. See the side-by-side table above.
Is NIRAMAI Health Analytix cheaper than OpenEvidence?
No — OpenEvidence's cheapest paid plan is Free, while NIRAMAI Health Analytix's is Enterprise · Contact sales.
Do NIRAMAI Health Analytix and OpenEvidence offer free plans?
NIRAMAI Health Analytix: Paid only. OpenEvidence: Yes, has a free plan.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.